Softgel Capsule Market Summary
As per MRFR Analysis, the Softgel Capsule Market was valued at 4.37 USD Billion in 2023 and is projected to grow to 8.5 USD Billion by 2035, with a CAGR of 5.7% from 2025 to 2035. The market is driven by rising demand for dietary supplements and nutraceuticals, advancements in softgel technology, an increasing aging population, and a growing preference for plant-based ingredients. Major companies are focusing on product innovation and expanding their offerings to meet consumer needs.
Key Market Trends & Highlights
Key trends driving the Softgel Capsule Market include:
- The global dietary supplements market is expected to grow from 140 billion USD in 2022 to 245 billion USD by 2024, with a CAGR of about 8%.
- The aging population is projected to double from 703 million in 2019 to 1.5 billion by 2050, increasing demand for health supplements.
- Plant-based food sales increased by 27% from 2018 to 2020, influencing the shift towards plant-based softgel capsules.
- Technological advancements in encapsulation are growing at a rate of 6.5% annually, enhancing product quality and stability.
Market Size & Forecast
2023 Market Size: USD 4.37 Billion
2024 Market Size: USD 4.62 Billion
2035 Market Size: USD 8.5 Billion
CAGR (2025-2035): 5.7%
Largest Regional Market Share in 2024: North America
Major Players
Procaps Group, Nutraceutical Corporation, Ginkgo BioWorks, Capsugel, Qualicaps, Swallow Solutions, Softgel Technologies, Alcami, BASF, Fagron, Heathwest, HPMC Caps, Amgen, Meda Pharmaceuticals
Key Softgel Capsule Market Trends Highlighted
The Softgel Capsule Market is seeing some big changes, mainly because more and more people want dietary supplements and nutraceuticals. Softgel capsules, which are easy to take, have grown quite popular as people become more health conscious. Also, improvements in technology are making the methods used to make softgels more efficient and of higher quality. The growth in new formulations, such as plant-based and gummy softgels, appeals to a wider range of customers, especially those who want vegetarian or vegan choices. There are more and more chances in the market, especially as global health programs push for wellness and preventative care.
Ā The softgel delivery technique is a good way for drug firms to make complicated formulations, including those needed for targeted medicines. There is also a growing trend toward customisation, where marketers may make softgel products that meet the unique demands of consumers, such as tastes and vitamin combinations. In recent years, more and more softgel items have been sold via e-commerce sites, making them easier for people all over the globe to get.Ā
This trend of more and more people purchasing online fits nicely with the worldwide digital revolution, which helps businesses reach more people. Also, new rules in different parts of the world are pushing manufacturers to be more open about where they get their ingredients and how they label their products. This helps build trust with customers.
Ā The Softgel Capsule Market is always changing because of these factors, and new ideas and customer preferences are always changing the kind of products that are available.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Softgel Capsule Market Drivers
Increasing Demand for Nutraceuticals
The Softgel Capsule Market Industry is witnessing a significant rise in demand for nutraceuticals, driven by a growing health-conscious population. According to the World Health Organization, the global prevalence of chronic diseases such as obesity and diabetes stands at around 34% and is projected to increase, which fosters the need for supplementary health products. For instance, pharmaceutical and dietary supplement companies like Abbott Laboratories and Herbalife are adapting their product lines to include softgel capsules as a delivery method, capitalizing on this trend.
The nutraceutical segment is expected to grow substantially, with softgels offering an easy-to-swallow and effective delivery option that resonates well with consumers. This growth potential indicates a favorable trajectory for the Softgel Capsule Market Industry as brands accelerate their offerings to meet shifting consumer requirements for healthier lifestyle choices.
Technological Advancements in Drug Delivery
Innovation in drug delivery systems presents a significant driver for the Softgel Capsule Market Industry. Recent advances in encapsulation technology have enhanced bioavailability, leading to improved therapeutic effects. Notably, the development of lipid-based softgel formulations has made it possible to deliver poorly soluble drugs more effectively. This improvement is in line with the findings from the International Pharmaceutical Federation, which emphasize the need for novel delivery methods to meet patient needs.
Established players such as Pfizer are increasingly investing in Research and Development (R&D) to explore these technologies, thus enhancing their product portfolios. As these advancements make softgel capsules a more attractive option for both patients and healthcare providers, the market growth is expected to strengthen accordingly.
Rising Aging Population
The Softgel Capsule Market Industry is also significantly driven by the rising aging population. The United Nations indicates that the percentage of the global population aged 60 and older is expected to increase from 12% in 2015 to 22% by 2050. This demographic shift results in higher incidences of age-related health conditions, leading to increased demand for supplements and medications, including softgel capsules. Companies such as Johnson & Johnson are actively focusing on developing products tailored for older adults, recognizing the extended longevity and the increased healthcare needs of this demographic.
As the global population ages, the demand for softgel capsules is anticipated to escalate, thereby positively impacting the market dynamics.
Growing Preference for Minimalistic Packaging
There is a noticeable trend towards minimalistic packaging in the pharmaceutical industry, which includes the Softgel Capsule Market Industry. The growing environmental awareness among consumers and manufacturers has led to a demand for more sustainable packaging options. Reports indicate that approximately 58% of consumers globally are willing to pay more for products that utilize sustainable packaging solutions. Major companies like GlaxoSmithKline are investing in eco-friendly packaging initiatives, thereby aligning their product offerings with consumer demands for environmentally conscious choices.
As the trend for minimalistic and sustainable packaging continues to grow, it is expected to bolster the market appeal of softgel capsules, augmenting their market share in the comprehensive global landscape.
Softgel Capsule Market Segment Insights
Softgel Capsule Market Application Insights
The Softgel Capsule Market segment focusing on Application reveals a substantial landscape that plays a critical role in various industries. By 2024, the market is projected to generate total revenue of 4.62 USD Billion, with significant contributions from individual applications within the sector. Notably, the Nutraceuticals application holds a prominent position, showcasing a valuation of 1.5 USD Billion in 2024 and expected to grow to 2.75 USD Billion by 2035, indicating its vital role in health and wellness. This sector has gained traction due to the rising consumer preference for preventive healthcare measures, as softgel capsules offer convenient and effective delivery of nutrients and supplements. Meanwhile, the Pharmaceuticals application, valued at 1.8 USD Billion in 2024 and poised to reach 3.4 USD Billion in 2035, underscores the importance of softgel capsules in delivering medication, as they enhance bioavailability and provide an additional layer of protection for sensitive ingredients.
The Cosmetics application, though smaller in size, with a valuation of 0.35 USD Billion in 2024 and growth to 0.65 USD Billion by 2035, is becoming increasingly significant as consumers seek multifunctional products that combine beauty benefits with health. Similarly, Vitamins, valued at 0.7 USD Billion in 2024 and expected to achieve a value of 1.3 USD Billion by 2035, underline the growing trend of vitamin supplementation among health-conscious individuals. Dietary Supplements, while at a lesser scale of 0.27 USD Billion in 2024, with projections of up to 0.6 USD Billion in 2035, reflect consumer demand for tailored nutritional solutions to enhance overall well-being, showcasing an opportunity for innovation in this space. The overall growth of these applications demonstrates an increasing awareness regarding health and wellness on a global scale, driven by demographic shifts and lifestyle changes.
Additionally, these applications reflect the dynamic nature of the Softgel Capsule Market industry, which is benefitting from technological advancements in capsule manufacturing that lead to improved product performance. Major growth drivers include health trends that prioritize holistic well-being, increased health expenditure, and the convenience associated with softgel formulations. However, challenges such as regulatory compliance and the need for high-quality raw materials can impact market dynamics. With the projected relevance and dominance of Nutraceuticals and Pharmaceuticals applications in constituting the majority of the market's valuation, the Softgel Capsule Market demonstrates a promising trajectory in addressing contemporary health needs and consumer preferences effectively. The increasing engagement in preventive healthcare illustrates how these applications are becoming indispensable in modern lifestyles, emphasizing the market's significant potential for continued growth in the coming years.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Softgel Capsule Market Ingredients Insights
The Softgel Capsule Market, particularly in its Ingredients segment, is projected to witness substantial growth, with a value of 4.62 USD Billion in 2024 and an expected rise to 8.5 USD Billion by 2035. The market growth is driven by increasing demand for dietary supplements and pharmaceuticals in the Global context, coupled with the beneficial properties of softgel capsules. Gelatin remains a dominant ingredient, prized for its biocompatibility and ability to encapsulate a variety of active ingredients effectively. Fish Gelatin is gaining traction due to its appeal in vegetarian and halal markets, offering an alternative to traditional gelatin sources.
Vegetable Gelatin, derived from plant-based materials, is becoming increasingly significant, aligning with the rising trend of veganism and clean-label products. Active Ingredients play a crucial role as they are essential for the therapeutic effectiveness of the capsules, while Colorants contribute to product differentiation in a competitive landscape. The Softgel Capsule Market segmentation highlights how various ingredients meet consumer preferences, with a growing emphasis on health and wellness, which presents numerous opportunities for innovation and expansion in the industry.
Companies are leveraging these trends to introduce new formulations that cater to diverse dietary needs, fueling market dynamics further.
Softgel Capsule Market Formulation Insights
The Softgel Capsule Market, with a projected value of 4.62 billion USD in 2024, showcases significant growth within the Formulation segment as it embraces diverse types such as Single Phase, Multi-Phase, Emulsified, Suspended, and Gelled formulations. These variations cater to a wide array of applications ranging from pharmaceuticals to nutraceuticals. Single Phase formulations are essential due to their simplicity and suitability for various compounds, making them widely used. Multi-Phase formulations often excel in offering enhanced bioavailability, which is crucial in the development of effective drug delivery systems.
Emulsified formulations play an important role in stabilizing agents, while Suspended and Gelled formulations provide unique textural options, enhancing user experience. This diversity addresses specific consumer needs and contributes to the overall growth of the market, projected to reach 8.5 billion USD by 2035. Growing demand for convenient dosage forms and advancements in manufacturing technology are key drivers for this segment's expansion within the Softgel Capsule Market. Furthermore, regulatory support for modern drug delivery systems adds to the opportunities for innovation and market growth, as companies increasingly focus on enhancing product effectiveness through diverse formulation strategies.
Softgel Capsule Market Distribution Channel Insights
The Softgel Capsule Market is expected to be valued at 4.62 USD Billion in 2024, with various distribution channels playing a pivotal role in its growth. Online retail has experienced a notable surge due to the convenience and accessibility it offers consumers, making it a significant factor in market dynamics. Pharmacies remain traditional leaders, providing trusted access to health supplements, while health stores offer specialized products that cater to niche markets, further enriching the distribution landscape. Supermarkets serve as a versatile channel, combining grocery shopping with wellness products, thereby attracting a larger customer base.
Direct sales facilitate personalized purchasing experiences, which resonate well with consumers looking for tailored health solutions. The diversity in distribution channels contributes to the overall market growth and offers various opportunities for stakeholders to capture specific consumer segments, ultimately enhancing the Softgel Capsule Market revenue. As consumer preferences shift toward holistic and convenient shopping experiences, these channels will continue to adapt and expand, thereby driving the market forward.
Softgel Capsule Market Regional Insights
The Softgel Capsule Market is witnessing robust growth across various regional segments, contributing significantly to the overall market dynamics. In 2024, the valuation for North America stands at 1.236 USD Billion, making it a major player in the market, with a notable growth trajectory expected to reach 2.186 USD Billion by 2035. Europe, valued at 1.023 USD Billion in 2024, follows closely, reflecting a substantial demand for softgel formulations, projected to grow to 1.781 USD Billion in the same timeframe. The Asia Pacific region is also significant, holding a 2024 valuation of 1.449 USD Billion and expected to surge to 2.671 USD Billion by 2035, driven by increasing health awareness and investment in pharmaceutical infrastructure.
South America, while smaller with a value of 0.213 USD Billion in 2024, is anticipated to grow steadily to 0.405 USD Billion in 2035. The Middle East and Africa, valued at 0.699 USD Billion in 2024, also show potential for growth, projected to reach 1.457 USD Billion in 2035. The geographical segmentation reflects varying demands influenced by local health trends and technological advancements, making these regions crucial for the Softgel Capsule Market revenue growth, with each region presenting unique opportunities and challenges within the Softgel Capsule Market industry landscape.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Softgel Capsule Market Key Players and Competitive Insights
The Softgel Capsule Market is characterized by a blend of innovation, technological advancements, and a diverse range of product offerings aimed at meeting the evolving needs of consumers. This market comprises various players, from large multinational corporations to niche manufacturers, each competing fiercely to secure a larger market share. With factors such as increasing health consciousness among consumers, the rising demand for dietary supplements, and the evolving regulations around pharmaceutical formulations, companies are continually strategizing to enhance their product formulations and expand their distribution networks. The competition often hinges on product differentiation, customer loyalty, and the ability to effectively respond to trends such as plant-based and vegan softgel alternatives.
Key Companies in the Softgel Capsule Market Include:
- Catalent
- Lonza
- ProCaps Laboratories
- Rottendorf Pharma
- EuroCaps
- Jubilant Pharmova
- Garuda International
- SoftGel Technologies
- Natural Capsules
Softgel Capsule Market Industry Developments
The Softgel Capsule Market has seen significant activity recently, particularly with companies like Lonza engaging in strategic initiatives to enhance their product offerings and manufacturing capabilities. Notably, in September 2023, Jubilant Pharmova expanded its production capabilities, enhancing its portfolio to meet rising consumer demand for nutritional supplements. Similarly, Catalent has been investing in technology upgrades for its softgel production lines to improve efficiency and product quality.
In terms of acquisitions, ProCaps Laboratories was involved in a strategic partnership in June 2023, which is expected to broaden its reach in the dietary supplements segment. Meanwhile, EuroCaps and SoftGel Technologies have also been engaged in collaborations to leverage shared resources for product innovation in the nutraceutical space. Over the past few years, the Softgel Capsule Market has exhibited robust growth, with a market valuation expected to increase significantly as consumer preferences shift towards convenient and effective dosage forms. The collective actions of these companies are shaping the market landscape as they respond to emerging health trends and consumer demands for high-quality dietary supplements.
Softgel Capsule Market Segmentation Insights
Softgel Capsule Market Application Outlook
- Nutraceuticals
- Pharmaceuticals
- Cosmetics
- Vitamins
- Dietary Supplements
Softgel Capsule Market Ingredients Outlook
- Gelatin
- Fish Gelatin
- Vegetable Gelatin
- Active Ingredients
- Colorants
Softgel Capsule Market Formulation Outlook
- Single Phase
- Multi-Phase
- Emulsified
- Suspended
- Gelled
Softgel Capsule Market Distribution Channel Outlook
- Online Retail
- Pharmacies
- Health Stores
- Supermarkets
- Direct Sales
Softgel Capsule Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
|
Report Attribute/Metric
|
Details
|
|
Market Size 2023
|
4.37(USD Billion)
|
|
Market Size 2024
|
4.62(USD Billion)
|
|
Market Size 2035
|
8.5(USD Billion)
|
|
Compound Annual Growth Rate (CAGR)
|
5.7% (2025 - 2035)
|
|
Report Coverage
|
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
|
|
Base Year
|
2024
|
|
Market Forecast Period
|
2025 - 2035
|
|
Historical Data
|
2019 - 2024
|
|
Market Forecast Units
|
USD Billion
|
|
Key Companies Profiled
|
Catalent, Lonza, ProCaps Laboratories, Rottendorf Pharma, EuroCaps, Jubilant Pharmova, Garuda International, SoftGel Technologies, Natural Capsules.
Ā
|
|
Segments Covered
|
Application, Ingredients, Formulation, Distribution Channel, Regional
|
|
Key Market Opportunities
|
Increasing demand for dietary supplements, Rising popularity of pharmaceutical softgels, Growth in the aging population, Advancements in softgel manufacturing technology, Expansion of the e-commerce distribution channel
|
|
Key Market Dynamics
|
rising demand for dietary supplements, growing pharmaceutical industry, increasing preference for capsule forms, advancements in softgel manufacturing technology, rising health awareness among consumers
|
|
Countries Covered
|
North America, Europe, APAC, South America, MEA
|
Softgel Capsule Market Highlights:
Frequently Asked Questions (FAQ) :
The Softgel Capsule Market is expected to be valued at 4.62 billion USD in 2024.
By 2035, the Softgel Capsule Market is projected to reach a value of 8.5 billion USD.
The market is anticipated to grow at a CAGR of 5.7% from 2025 to 2035.
The Pharmaceuticals segment is anticipated to dominate, valued at 3.4 billion USD in 2035.
The market is segmented into North America, Europe, South America, Asia Pacific, and the Middle East and Africa.
In 2024, the North American market is expected to be valued at 1.236 billion USD.
The Asia Pacific market is projected to reach 2.671 billion USD by 2035.
Major players include Lonza, Catalent, and ProCaps Laboratories, among others.
The Nutraceuticals application is expected to reach a value of 1.5 billion USD in 2024.
Emerging trends and challenges are driven by increasing demand for health supplements and regulatory changes.
